Global SRS Immobilization Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

SRS Immobilization Devices Market Size

• The global SRS immobilization devices market size was valued at USD 1.2 billion in 2025and is expected to reach USD 2.2 billion by 2033, at a CAGR of 8.3% during the forecast period
• Growth is driven by increasing demand for high-precision radiotherapy procedures, as immobilization devices play a critical role in ensuring accurate patient positioning and minimizing movement during stereotactic radiosurgery and stereotactic body radiotherapy, thereby improving treatment outcomes and safety
• Rising adoption of advanced radiotherapy techniques such as SRS, SBRT, and image-guided radiotherapy across hospitals and cancer treatment centers is accelerating market expansion, as these procedures require reliable immobilization solutions to maintain reproducibility and precision throughout treatment sessions

SRS Immobilization Devices Market Analysis

• SRS immobilization devices, which provide capabilities such as patient stabilization, reproducible positioning, motion restriction, and treatment accuracy enhancement, are becoming essential components across radiation oncology procedures, particularly in stereotactic radiosurgery and stereotactic body radiotherapy due to their ability to ensure precise radiation delivery and improve clinical outcomes
• The escalating demand for SRS immobilization devices is primarily driven by the increasing global burden of cancer, rising adoption of high-precision radiotherapy techniques, and growing need for minimizing patient movement during treatment, along with continuous advancements in material technologies such as thermoplastics and customized patient-specific devices that enhance comfort and accuracy
• North America dominated the SRS immobilization devices market with the largest revenue share of approximately 36.8% in 2025, supported by advanced healthcare infrastructure, high adoption of precision radiotherapy technologies, and strong presence of key market players
• Asia-Pacific is expected to be the fastest growing region in the SRS immobilization devices market during the forecast period due to increasing cancer incidence, expanding radiotherapy infrastructure, and rising healthcare investments across emerging economies such as China and India
• The thermoplastic masks segment dominated the SRS immobilization devices market with a market share of approximately 34.5% in 2025, driven by their widespread use in head and neck immobilization procedures due to ease of customization, reusability, and improved patient comfort

Report Scope and SRS Immobilization Devices Market Segmentation

SRS Immobilization Devices Market Trends

“Growing Adoption of Advanced and Patient-Specific Immobilization Solutions”

• A significant and accelerating trend in the global SRS immobilization devices market is the increasing shift toward advanced, patient-specific immobilization solutions that enhance treatment precision while improving patient comfort across radiation oncology procedures
• For instance, companies are increasingly developing customized thermoplastic masks and vacuum-based immobilization systems designed to provide accurate patient positioning and reproducibility during stereotactic radiosurgery and stereotactic body radiotherapy procedures
• Technological advancements in material science and device design are enabling the development of immobilization devices with improved flexibility, durability, and compatibility with advanced imaging and radiotherapy systems, helping healthcare providers maintain high treatment accuracy
• The increasing adoption of high-precision radiotherapy techniques such as SRS and SBRT is supporting the demand for immobilization devices that ensure minimal patient movement and consistent positioning throughout treatment sessions
• This trend toward advanced and high-performance immobilization solutions is reshaping industry expectations for treatment accuracy, workflow efficiency, and patient safety across hospitals and cancer treatment centers
• The demand for innovative immobilization devices with improved ergonomics, customization capabilities, and integration with digital planning systems is growing rapidly across both developed and emerging healthcare markets
• Increasing adoption of image-guided radiotherapy and adaptive treatment approaches is further driving the need for reliable immobilization solutions to support real-time accuracy and precision in cancer treatment

SRS Immobilization Devices Market Dynamics

Driver

“Rising Demand for High-Precision Radiotherapy and Motion Management”

• The increasing demand for high-precision radiotherapy procedures, coupled with the rising global burden of cancer, is a major driver fueling the growth of the SRS immobilization devices market globally
• For instance, healthcare systems in regions such as North America and Europe are encouraging the adoption of advanced radiotherapy technologies that require accurate patient positioning and motion control to improve treatment outcomes
• As healthcare providers focus more on enhancing treatment accuracy and reducing radiation exposure to healthy tissues, immobilization devices play a critical role in ensuring reproducible positioning and stability during treatment
• Furthermore, the growing adoption of advanced radiotherapy techniques such as stereotactic radiosurgery, stereotactic body radiotherapy, and image-guided radiotherapy is increasing the demand for high-performance immobilization solutions
• The versatility of these devices across applications such as brain tumor treatment, spine radiotherapy, and lung cancer treatment is driving widespread adoption in modern oncology practices
• Expanding healthcare infrastructure and increasing investments in cancer treatment facilities in emerging economies are further supporting market growth
• Government initiatives and healthcare policies promoting advanced cancer care are accelerating the adoption of SRS immobilization devices globally

Restraint/Challenge

“High Cost and Operational Complexity of Advanced Devices”

• challenges related to the high cost of advanced SRS immobilization devices and their customization pose significant barriers to large-scale adoption, particularly in developing regions
• For instance, the implementation of these devices requires specialized materials, advanced manufacturing processes, and trained professionals, which can increase overall operational costs for healthcare providers
• Addressing these challenges through cost-effective material innovations, scalable production methods, and training programs is critical for improving market accessibility
• While demand for high-precision radiotherapy is increasing, complexities related to device customization, patient-specific fitting, and workflow integration can limit efficient utilization in certain clinical settings
• Overcoming these challenges through continuous innovation, improved device design, and enhanced compatibility with radiotherapy systems will be essential for long-term market growth
• Stringent regulatory requirements and quality standards can also increase compliance costs and product approval timelines, potentially affecting market expansion

SRS Immobilization Devices Market Scope

The market is segmented on the basis of product, source, form, and application.

• By Product

on the basis of product, the global SRS immobilization devices market is segmented into thermoplastic masks, vacuum cushions, headrests, stereotactic frames, bite blocks, and others. The thermoplastic masks segment dominated the market with the largest revenue share of approximately 34.5% in 2025, driven by their extensive use in head and neck immobilization during stereotactic radiosurgery procedures due to their ease of customization, strong fixation capability, and improved patient comfort. Thermoplastic masks are widely preferred as they allow reproducible positioning and compatibility with advanced imaging and treatment planning systems, supporting their widespread adoption across radiotherapy centers. Their increasing use in precision oncology treatments, along with continuous advancements in material flexibility and durability, is further strengthening segment dominance globally.

The stereotactic frames segment is expected to witness the fastest growth during the forecast period, fueled by rising demand for ultra-high precision in intracranial procedures and increasing adoption in advanced radiosurgery systems. Growing use in complex neurological treatments and technological advancements in frame design are further accelerating segment growth globally.

• By Material

On the basis of material, the market is segmented into thermoplastic materials, foam-based materials, vacuum-based systems, carbon fiber-based materials, and others. The thermoplastic materials segment dominated the market with the largest revenue share in 2025, driven by their flexibility, ease of molding, and ability to provide precise and stable patient immobilization. These materials are widely used in mask fabrication and positioning devices, making them essential in stereotactic treatment procedures. Their compatibility with imaging technologies and increasing adoption in customized patient-specific solutions are further supporting segment dominance.

The vacuum-based systems segment is expected to witness the fastest growth during the forecast period, fueled by increasing demand for body immobilization in stereotactic body radiotherapy and advancements in customizable positioning solutions that enhance treatment accuracy and reproducibility.

• By Form

On the basis of form, the market is segmented into rigid immobilization devices, flexible immobilization devices, and customized patient-specific devices. The rigid immobilization devices segment dominated the market with the largest revenue share in 2025, driven by their ability to provide strong fixation and stability required for high-precision radiotherapy procedures. These devices are widely used in intracranial treatments where minimal patient movement is critical for accurate radiation delivery.

The customized patient-specific devices segment is expected to witness the fastest growth during the forecast period, fueled by increasing demand for personalized treatment solutions and advancements in 3D printing and material technologies that enable better patient fit and comfort.

• By Application

On the basis of application, the market is segmented into brain tumors, spine tumors, lung cancer, prostate cancer, head and neck cancer, and other indications. The brain tumor segment dominated the market with the largest revenue share of approximately 41.2% in 2025, driven by the widespread use of stereotactic radiosurgery for intracranial lesions and neurological disorders requiring high precision. The need for accurate patient positioning and motion control in brain treatments is significantly supporting demand for immobilization devices in this segment.

The lung cancer segment is expected to witness the fastest growth during the forecast period, fueled by increasing global incidence of lung cancer and rising adoption of stereotactic body radiotherapy, which requires advanced immobilization solutions for effective motion management during treatment.

SRS Immobilization Devices Market Regional Analysis

• North America dominated the SRS immobilization devices market with the largest revenue share of approximately 36.8% in 2025, supported by advanced healthcare infrastructure, high adoption of precision radiotherapy technologies, and strong presence of leading market players. The region benefits from well-established oncology centers, increasing use of stereotactic radiosurgery and stereotactic body radiotherapy procedures, and continuous advancements in treatment delivery systems, particularly in the United States and Canada
• Healthcare providers and device manufacturers in the region place significant emphasis on improving treatment accuracy, patient positioning, and integration of immobilization systems with advanced imaging and radiotherapy platforms, leading to widespread utilization of SRS immobilization devices across hospitals and cancer treatment centers. This strong market position is further supported by increasing healthcare expenditure, rising cancer prevalence, and continuous investments in oncology care infrastructure, establishing immobilization devices as critical components in high-precision radiotherapy workflows

U.S. SRS Immobilization Devices Market Insight

The U.S. SRS immobilization devices market captured the largest revenue share within North America in 2025, driven by high adoption of advanced radiotherapy technologies, strong presence of specialized cancer treatment centers, and increasing demand for precision oncology solutions. The growing prevalence of cancer and increasing preference for minimally invasive treatment approaches continue to drive market growth. Additionally, advancements in immobilization technologies and integration with treatment planning systems significantly contribute to sustained market expansion

Europe SRS Immobilization Devices Market Insight

The Europe SRS immobilization devices market is projected to expand at a steady CAGR throughout the forecast period, primarily driven by increasing adoption of advanced radiotherapy solutions and strong regulatory support for high-quality cancer care. Healthcare systems in the region emphasize patient safety, treatment precision, and integration of advanced technologies, fostering consistent adoption of immobilization devices across hospitals and oncology centers. Growth is further supported by rising investments in healthcare infrastructure and expanding access to advanced radiotherapy services.

U.K. SRS Immobilization Devices Market Insight

The U.K. SRS immobilization devices market is anticipated to grow at a notable CAGR during the forecast period, supported by increasing demand for precision cancer treatment and expansion of radiotherapy services. Rising adoption of advanced treatment techniques and strong focus on improving clinical outcomes are driving demand across healthcare facilities. The country’s well-established healthcare system and ongoing investments in oncology infrastructure are accelerating the adoption of SRS immobilization devices

Germany SRS Immobilization Devices Market Insight

The Germany SRS immobilization devices market is expected to expand at a considerable CAGR during the forecast period, driven by strong focus on technological innovation and high adoption of advanced medical devices. Germany’s emphasis on precision medicine, high-quality healthcare services, and integration of advanced radiotherapy technologies supports the widespread use of immobilization devices. Increasing investments in research and development and strong healthcare infrastructure further contribute to market growth

Asia-Pacific SRS Immobilization Devices Market Insight

The Asia-Pacific SRS immobilization devices market is poised to grow at the fastest CAGR during the forecast period of 2026 to 2033, driven by increasing cancer incidence, expanding radiotherapy infrastructure, and rising investments in advanced oncology technologies. Countries such as China, India, and Japan play a key role in expanding access to cancer treatment services. Rising healthcare expenditure, growing awareness regarding advanced treatment options, and government initiatives to strengthen cancer care infrastructure are accelerating market growth across the region

Japan SRS Immobilization Devices Market Insight

The Japan SRS immobilization devices market is gaining momentum due to strong focus on advanced medical technologies and high-quality healthcare services. Increasing adoption of precision radiotherapy procedures and integration of advanced imaging technologies are driving demand. The country’s emphasis on innovation and technological advancement supports the development and adoption of advanced immobilization solutions across healthcare facilities

India SRS Immobilization Devices Market Insight

The India SRS immobilization devices market accounted for a growing share in Asia-Pacific in 2025, attributed to increasing cancer prevalence, expanding healthcare infrastructure, and rising investments in oncology care. Growing awareness regarding advanced treatment options and increasing adoption of radiotherapy technologies are driving demand. Government initiatives aimed at improving cancer care facilities and expanding access to advanced treatment technologies are key factors supporting sustained market growth in India

SRS Immobilization Devices Market Share

The SRS Immobilization Devices industry is primarily led by well-established companies, including:

• CIVCO Radiotherapy (U.S.)
• Qfix (Avondale Medical) (U.S.)
• Orfit Industries NV (Belgium)
• Klarity Medical Products (China)
• MacroMedics (Netherlands)
• Bionix Radiation Therapy (U.S.)
• IZI Medical Products (U.S.)
• Medtec Medical, Inc. (U.S.)
• Sun Nuclear Corporation (U.S.)
• Standard Imaging, Inc. (U.S.)
• Candor Denmark ApS (Denmark)
• IT-V Innovative Technologies Völp (Germany)
• Radiation Products Design, Inc. (U.S.)
• Panacea Medical Technologies Pvt. Ltd. (India)
• Moldcare (India)
• Leo Cancer Care (U.K.)
• CQ Medical (U.S.)
• Guangzhou Renfu Medical Equipment (China)
• Radian Healthcare (India)
• KRS India (India)

What are the Recent Developments in Global SRS Immobilization Devices Market?

• In September 2025, CQ Medical expanded its SRS immobilization devices portfolio by introducing an upgraded Integrated Shim System designed to improve head and neck positioning accuracy, enhance treatment stability, and reduce setup errors in stereotactic radiosurgery procedures
• In July 2025, CIVCO Radiotherapy enhanced its SRS immobilization devices portfolio by launching advanced thermoplastic mask systems aimed at improving patient comfort, reproducibility, and precision during high-dose radiotherapy treatments
• In May 2025, research institutes developed a novel 3D-printed patient-specific immobilization device designed to improve anatomical fit, enhance positioning accuracy, and support personalized radiotherapy treatment approaches
• In March 2025, Orfit Industries NV expanded its SRS immobilization devices portfolio by introducing advanced vacuum-based immobilization solutions aimed at improving stability and motion control during stereotactic body radiotherapy procedures
• In January 2024, Qfix strengthened its SRS immobilization devices offerings by upgrading its patient positioning systems with improved ergonomic design and compatibility with image-guided radiotherapy platforms to enhance treatment accuracy and workflow efficiency

SKU-76212